Genetics: The next step in Mendelian randomization
Expanding a statistical approach called Mendelian randomization to include multiple variables may help researchers to identify new molecular causes of specific traits.
- Cologne Excellence Cluster on Cellular Stress Responses in Age‐Associated Diseases, and the Institute for Biochemistry, University of Cologne, Germany
- Cologne Excellence Cluster on Cellular Stress Responses in Age‐Associated Diseases, the Faculty of Medicine and University Hospital of Cologne, the Center for Molecular Medicine Cologne, and the Institute for Genetics, University of Cologne, Germany
Understanding how variations in our genome influence our susceptibility to diseases is one of the most compelling research topics in the life sciences. Researchers have used genome-wide association studies – experiments that analyze the DNA sequences of multiple individuals – to identify statistical relationships between genetic variants and specific human traits, such as susceptibility to a disease or various body parameters.
Despite the success of this approach, major challenges persist. First, associations between variants that are located close to each other within the genome can make it difficult to determine which of these genetic changes are responsible for the phenotype of interest (a problem called linkage disequilibrium). Second, even if specific variants can be identified, it is often not straightforward to determine the molecular mechanism by which they impact the trait (Tam et al., 2019).
To overcome these difficulties, studies often include information about other modalities such as transcriptomes, proteins and metabolites (Emilsson et al., 2008; Fraser and Xie, 2009; Nicolae et al., 2010; Wainberg et al., 2019; Schadt, 2009; Suhre et al., 2011). Some ‘multi-omic’ studies use one modality, or ‘layer’, to confirm changes to another, such as confirming changes in levels of mRNA by measuring the respective protein product. However, there is a shortage of examples of mechanistic links between the different layers (Buccitelli and Selbach, 2020; Wörheide et al., 2021). Now, in eLife, Zoltán Kutalik, Eleonora Porcu and colleagues from the Swiss Institute of Bioinformatics and the University of Lausanne – including Chiara Auwerx as first author – report a new approach that uses a technique called Mendelian randomization to reveal a chain of molecular connections between the transcriptome, metabolome, and high-level physiological traits such as biomarkers associated with kidney health (Auwerx et al., 2023).
Mendelian randomization is considered to be an ‘experiment of nature’, as it uses variations already present in the genetic code to determine if exposure to certain conditions (such as the amount of cholesterol in the blood, or the expression level of a gene) affects a specific trait (for instance, increased susceptibility to heart disease). The genetic variants act as a proxy, or ‘instrument’, for exposures that are difficult or impossible to manipulate in the population being studied. Mediation analysis can then be applied to ask if the exposure is responsible for the effects of the instrumental variable on the trait of interest. However, it is necessary to proceed carefully (Sanderson et al., 2022): for example, the instrumental variable being used should not affect the trait of interest through any other mediator.
The computational framework presented by Auwerx et al. integrates results from genome-wide association studies with data on genetic variants that affect the level of transcripts or the composition of metabolites. These variants are typically referred to as eQTL (short for expression quantitative trait loci) and mQTL (metabolite QTL), and can be derived from separate population cohorts, allowing researchers to tap into the vast resources of information that are already available.
First, causal links between transcripts and metabolites are established using overlapping mQTL and eQTL as instrumental variables. Causal effects of metabolites on traits of interest are then determined in the same manner using mQTL and genetic variants identified in genome-wide association studies. The next step in the framework is purely based on this established causality: transcripts that causally affect trait-modifying metabolites have to be causally linked to the same trait, resulting in transcript-metabolite-trait triplets (Figure 1). A statistical calculation, known as multivariate Mendelian randomization, is then performed on these triplets using the metabolite-associated variants as the instrumental variable. This determines what proportion of change in the outcome is a result of the transcript directly (or via unknown mediators) impacting the trait, and what proportion is the result of changes in the level of the metabolite mediating the relationship between them.
Figure 1
Mendelian randomization with multiple variables.
In the first step, Mendelian randomization calculations establish causal links between: (i) transcripts (T; pink chains) and metabolites (M; green hexagons) using eQTL and mQTL as instrumental variables (IV; first row); (ii) metabolites and various phenotypes (Y, such as height), using mQTL and the genetic variants associated with the traits as instrumental variables (second row). These causal links are then overlapped to establish causal triplets (third row). These causal triplets are subsequently analyzed in another Mendelian randomization-based calculation, which evaluates the effect of the respective mQTL on the levels of the transcripts, metabolites and traits of the triplet (fourth row). From this multivariate Mendelian randomization (MWMR), the proportion of transcript changes that directly effect a trait, and the proportion that cause an effect via metabolites, can be inferred. eQTL: expression quantitative trait loci; mQTL: metabolite quantitative trait loci.
Image credit: Figure created using BioRender (CC BY 4.0).
Auwerx et al. highlight an intriguing example of genetic variants affecting the transcription of a citrate-exporting protein encoded by a gene called ANKH that has been implicated in mineralization disorders. The resulting change to the export of citrate seems to affect the level of calcium present in the serum of individuals – a connection that was not detected when only transcript levels were correlated with the calcium trait.
By extending the Mendelian randomization approach to include two modalities (transcripts and metabolites), this new framework can detect causal relationships that could not be identified by comparing the genome wide association data to a single modality only. It also provides new insights into how the transcript impacts the phenotype through metabolic changes. With multi-omics studies increasing further in size, it is highly probable that even more advanced statistical approaches may become feasible in the future.
References
-
MRNAs, proteins and the emerging principles of gene expression controlNature Reviews Genetics 21:630–644.https://doi.org/10.1038/s41576-020-0258-4
-
Common polymorphic transcript variation in human diseaseGenome Research 19:567–575.https://doi.org/10.1101/gr.083477.108
-
Mendelian randomizationNature Reviews Methods Primers 2:e00092-5.https://doi.org/10.1038/s43586-021-00092-5
-
Benefits and limitations of genome-wide association studiesNature Reviews Genetics 20:467–484.https://doi.org/10.1038/s41576-019-0127-1
-
Multi-omics integration in biomedical research - a metabolomics-centric reviewAnalytica Chimica Acta 1141:144–162.https://doi.org/10.1016/j.aca.2020.10.038
Article and author information
Author details
Publication history
Copyright
© 2023, Weith and Beyer
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,795
- views
-
- 202
- downloads
-
- 27
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Genetics: The next step in Mendelian randomization
eLife 12:e86416.
https://doi.org/10.7554/eLife.86416
Further reading
-
- Genetics and Genomics
- Microbiology and Infectious Disease
Polyamines are biologically ubiquitous cations that bind to nucleic acids, ribosomes, and phospholipids and, thereby, modulate numerous processes, including surface motility in Escherichia coli. We characterized the metabolic pathways that contribute to polyamine-dependent control of surface motility in the commonly used strain W3110 and the transcriptome of a mutant lacking a putrescine synthetic pathway that was required for surface motility. Genetic analysis showed that surface motility required type 1 pili, the simultaneous presence of two independent putrescine anabolic pathways, and modulation by putrescine transport and catabolism. An immunological assay for FimA—the major pili subunit, reverse transcription quantitative PCR of fimA, and transmission electron microscopy confirmed that pili synthesis required putrescine. Comparative RNAseq analysis of a wild type and ΔspeB mutant which exhibits impaired pili synthesis showed that the latter had fewer transcripts for pili structural genes and for fimB which codes for the phase variation recombinase that orients the fim operon promoter in the ON phase, although loss of speB did not affect the promoter orientation. Results from the RNAseq analysis also suggested (a) changes in transcripts for several transcription factor genes that affect fim operon expression, (b) compensatory mechanisms for low putrescine which implies a putrescine homeostatic network, and (c) decreased transcripts of genes for oxidative energy metabolism and iron transport which a previous genetic analysis suggests may be sufficient to account for the pili defect in putrescine synthesis mutants. We conclude that pili synthesis requires putrescine and putrescine concentration is controlled by a complex homeostatic network that includes the genes of oxidative energy metabolism.
-
- Genetics and Genomics
Resistance to anthelmintics, particularly the macrocyclic lactone ivermectin (IVM), presents a substantial global challenge for parasite control. We found that the functional loss of an evolutionarily conserved E3 ubiquitin ligase, UBR-1, leads to IVM resistance in Caenorhabditis elegans. Multiple IVM-inhibiting activities, including viability, body size, pharyngeal pumping, and locomotion, were significantly ameliorated in various ubr-1 mutants. Interestingly, exogenous application of glutamate induces IVM resistance in wild-type animals. The sensitivity of all IVM-affected phenotypes of ubr-1 is restored by eliminating proteins associated with glutamate metabolism or signaling: GOT-1, a transaminase that converts aspartate to glutamate, and EAT-4, a vesicular glutamate transporter. We demonstrated that IVM-targeted GluCls (glutamate-gated chloride channels) are downregulated and that the IVM-mediated inhibition of serotonin-activated pharynx Ca2+ activity is diminished in ubr-1. Additionally, enhancing glutamate uptake in ubr-1 mutants through ceftriaxone completely restored their IVM sensitivity. Therefore, UBR-1 deficiency-mediated aberrant glutamate signaling leads to ivermectin resistance in C. elegans.
